![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Antunes C. M., Strolley P. D., Rosenhein N. B. Endometrial cancer and oestrogen use. New England Journal of Medicine 1979; 300: 9–13
- Bonte J. The response of hyperplastic dysplastic and neoplastic endometrium to progestational therapy. Hormonal Biology of Endometrial Cancer, G. S. Richardson, D. T. MacLaughlin. VICC Technical Report Series, VICC, Geneva 1978; Volume 42: 155–87
- Bonte J. Medroxyprogesterone in the management of endometrial cancer. Progestogens in the Management of Hormone Responsive Cancers, R. W. Taylor. The Medicine Publishing Foundation, Oxford 1980; 35–46
- Bonte J., Decoster J. M., Ide P., Billiet G. Hormonoprophylaxis and hormonotherapy in its treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate. Gynecologic Oncology 1978; 6: 60–75
- Bonte J., Ide P., Billiet G., Wynants P. Tamoxifen as a possible chemotherapeutic agent in endometrial adrenocarcinoma. Gynecologic Oncology 1981; 11: 140–161
- Hammond C. B., Jelovsek F. R., Lee K. L. Effects of long-term estrogen replacement therapy. II. Neoplasia. American Journal of Obstetrics and Gynecology 1979; 133: 537–545
- Jänne O. A. Progesterone action in mammalian uterus. Acta Obstetricia et Gynecologica Scandinavica 1981; 101: 11–16, Supplement
- Judd H. L., Davidson B. J., Frumar A. M., Shamonki I. M., Lagasse L. D., Ballon S. C. Serum androgens and estrogens in women with and without endometrial cancer. American Journal of Obstetrics and Gynecology 1980; 136: 859–871
- Kelley R. M., Baker W. H. Progestational agents in the treatment of carcinoma of the endometrium. New England Journal of Medicine 1961; 264: 216–222
- Kottmeier H. L. Annual Report on the Results of Treatment m Gynaecological Cancer. Stockholm. Radiumhemmet. 1979; 17: 41
- MacDonald P. C., Rombaut R. P., Siiteri P. K. Plasma precursors of estrogen. I. Extent of conversion of plasma delta-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females. Journal of Clinical Endocrinology and Metabolism 1967; 27: 1103–1111
- MacDonald P. C., Edman C. D., Hemsell D. L., Porter J. C., Siiteri P K. Effect of obesity on conversion of androstenedione to estrone in postmenopausal women with and without endometrial cancer. American Journal of Obstetrics and Gynecology 1978; 130: 448–455
- Sherman A. I., Brown S. The precursors of endometrial cancer. American Journal of Obstetrics and Gynecology 1979; 135: 947–956
- Singer A. A review of the present situation. Controversies in Gynaecological Oncology, J. Jordan, A. Singer. Royal College of Obstetricians and Gynaecologists, London 1981; 1–24